» Articles » PMID: 27718061

Society of Behavioral Medicine Supports Increasing HPV Vaccination Uptake: an Urgent Opportunity for Cancer Prevention

Overview
Date 2016 Oct 9
PMID 27718061
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Human papillomavirus (HPV) vaccine coverage remains low in the USA. The Society for Behavioral Medicine (SBM) supports the goals outlined by Healthy People 2020, the President's Cancer Panel, and the National Vaccine Advisory Committee to increase vaccination coverage among both males and females. SBM makes the following recommendations in support of efforts to reduce structural and other barriers to HPV vaccination services in order to increase rates of series completion. We encourage legislators and other policymakers to improve administration authority, insurance coverage, and reimbursement rates to healthcare providers who make the HPV vaccine available to adolescents; provide instrumental support to fund the development of school curricula on HPV vaccination; and increase public awareness that HPV vaccination can prevent cancer. We urge healthcare providers and healthcare systems to increase the strength, quality, and consistency of HPV vaccination recommendations for all eligible patients; to treat HPV vaccination as a routine preventive service; employ culturally appropriate communication strategies in clinical settings to educate eligible patients, parents, and guardians about the importance, effectiveness, and safety of HPV vaccination; and to strengthen and better coordinate the use of electronic medical records and immunization information systems.

Citing Articles

Application of theoretical frameworks on human papillomavirus vaccine interventions in the United States: systematic review and meta-analysis.

Cotache-Condor C, Peterson M, Asare M Cancer Causes Control. 2021; 33(1):15-24.

PMID: 34705121 DOI: 10.1007/s10552-021-01509-y.


Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.

Lee C, Tseng C, Chang C, Lee M, Yang S Front Immunol. 2021; 12:626582.

PMID: 34054800 PMC: 8149888. DOI: 10.3389/fimmu.2021.626582.


Internal and External Validity of Social Media and Mobile Technology-Driven HPV Vaccination Interventions: Systematic Review Using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) Framework.

Asare M, Popelsky B, Akowuah E, Lanning B, Montealegre J Vaccines (Basel). 2021; 9(3).

PMID: 33652809 PMC: 7996801. DOI: 10.3390/vaccines9030197.


A 6-year update of the health policy and advocacy priorities of the Society of Behavioral Medicine.

Buscemi J, Bennett G, Gorin S, Pagoto S, Sallis J, Wilson D Transl Behav Med. 2017; 7(4):903-911.

PMID: 28573355 PMC: 5684079. DOI: 10.1007/s13142-017-0507-z.

References
1.
Ng J, Ye F, Roth L, Sobel K, Byron S, Barton M . Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64(42):1185-9. DOI: 10.15585/mmwr.mm6442a1. View

2.
. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010; 59(20):630-2. View

3.
Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans L, Singleton J, Curtis C . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(29):784-92. PMC: 4584833. DOI: 10.15585/mmwr.mm6429a3. View

4.
Kessels S, Marshall H, Watson M, Braunack-Mayer A, Reuzel R, Tooher R . Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012; 30(24):3546-56. DOI: 10.1016/j.vaccine.2012.03.063. View

5.
Berkowitz Z, Malone M, Rodriguez J, Saraiya M . Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012. Prev Med. 2015; 81:405-11. PMC: 6711477. DOI: 10.1016/j.ypmed.2015.10.007. View